128 related articles for article (PubMed ID: 12003186)
21. A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.
Gesme DH; Jett JR; Schreffler DD; Su JQ; Mailliard JA; Foley JF; Krook JE; Maksymiuk AW; Hatfield AK; Ebbert LP
Cancer; 1993 May; 71(9):2723-6. PubMed ID: 8385564
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of amonafide in advanced breast cancer.
Scheithauer W; Dittrich C; Kornek G; Haider K; Linkesch W; Gisslinger H; Depisch D
Breast Cancer Res Treat; 1991 Dec; 20(1):63-7. PubMed ID: 1813070
[TBL] [Abstract][Full Text] [Related]
23. Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
O'Brien S; Benvenuto JA; Estey E; Beran M; Felder TB; Keating M
Cancer Res; 1991 Feb; 51(3):935-8. PubMed ID: 1988134
[TBL] [Abstract][Full Text] [Related]
24. Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.
Higano CS; Goodman P; Craig JB; Kish JA; Rivkin SE; Wolf M; Crawford ED
Invest New Drugs; 1991 Nov; 9(4):361-3. PubMed ID: 1804814
[TBL] [Abstract][Full Text] [Related]
25. Amonafide as first-line chemotherapy for metastatic breast cancer.
Kornek G; Raderer M; Depisch D; Haider K; Fazeny B; Dittrich C; Scheithauer W
Eur J Cancer; 1994; 30A(3):398-400. PubMed ID: 8204367
[TBL] [Abstract][Full Text] [Related]
26. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
Asbury RF; Blessing JA; Soper JT
Am J Clin Oncol; 1994 Apr; 17(2):125-8. PubMed ID: 8141104
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of amonafide in advanced pancreatic adenocarcinoma.
Linke K; Pazdur R; Abbruzzese JL; Ajani JA; Winn R; Bradof JE; Daugherty K; Levin B
Invest New Drugs; 1991 Nov; 9(4):353-6. PubMed ID: 1804812
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Asbury R; Blessing JA; Look KY; Buller R; Lucci JA
Am J Clin Oncol; 1997 Dec; 20(6):626-7. PubMed ID: 9391554
[TBL] [Abstract][Full Text] [Related]
29. Phase I clinical investigation of amonafide.
Saez R; Craig JB; Kuhn JG; Weiss GR; Koeller J; Phillips J; Havlin K; Harman G; Hardy J; Melink TJ
J Clin Oncol; 1989 Sep; 7(9):1351-8. PubMed ID: 2549205
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of amonafide in patients with recurrent glioma.
Levitt R; Buckner JC; Cascino TL; Burch PA; Morton RF; Westberg MW; Goldberg RM; Gallagher JG; O'Fallon JR; Scheithauer BW
J Neurooncol; 1995; 23(1):87-93. PubMed ID: 7623074
[TBL] [Abstract][Full Text] [Related]
31. Advanced colorectal adenocarcinoma: treatment with amonafide.
Marschke RF; Wieand HS; O'Connell MJ; Rubin J; Schutt AJ; Burch PA; Kovach JS
J Natl Cancer Inst; 1994 Jun; 86(12):944-5. PubMed ID: 8196086
[No Abstract] [Full Text] [Related]
32. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
Rosen F; Vokes EE; Lad T; Kies M; Wade J; Kilton LJ; Blough R; French S; Mullane M; Benson AB
Invest New Drugs; 1995; 13(3):249-52. PubMed ID: 8729954
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of amonafide in cervical cancer, phase II. A SWOG study.
Malviya VK; Liu PY; Alberts DS; Surwit EA; Craig JB; Hannigan EV
Am J Clin Oncol; 1992 Feb; 15(1):41-4. PubMed ID: 1550078
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
Evans WK; Eisenhauer EA; Cormier Y; Ayoub J; Wierzbicki R; Laberge F; Shepherd FA
J Clin Oncol; 1990 Mar; 8(3):390-5. PubMed ID: 2155309
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.
Berger MZ; Kris MG; Gralla RJ; Marks LD; Potanovich LM; Dimaggio JJ; Heelan RT
Am J Clin Oncol; 1991 Apr; 14(2):124-6. PubMed ID: 1851387
[TBL] [Abstract][Full Text] [Related]
36. Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group study.
Poplin E; Fleming T; MacDonald JS; Eisenberg P; Fisher RI; Conrad ME
Invest New Drugs; 1993 Feb; 11(1):47-51. PubMed ID: 8349435
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of amonafide dosing based on acetylator phenotype.
Ratain MJ; Mick R; Berezin F; Janisch L; Schilsky RL; Vogelzang NJ; Lane LB
Cancer Res; 1993 May; 53(10 Suppl):2304-8. PubMed ID: 8485716
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of Amonafide in dogs.
Lu K; McLean MA; Vestal ML; Newman RA
Cancer Chemother Pharmacol; 1988; 21(2):134-8. PubMed ID: 3349561
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of mitonafide in non-small cell lung cancer (NSCLC).
Casado A; Rosell R; García-Gómez R; Díaz-Rubio E; Pérez-Manga G; Font A; Benavides A; Martín M
Invest New Drugs; 1996; 14(4):415-7. PubMed ID: 9157079
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of mitonafide in solid tumors.
Llombart M; Poveda A; Forner E; Fernández-Martos C; Gaspar C; Muñoz M; Olmos T; Ruiz A; Soriano V; Benavides A
Invest New Drugs; 1992 Aug; 10(3):177-81. PubMed ID: 1428727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
